Wichita Urology Group PA is a clinical research site located in Wichita, Kansas, United States 67226.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Wichita Urology Group PA has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Wichita Urology Group PA has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wichita Urology Group PA has 2 clinical trials on record, with 2 currently active. Their work covers Progressive Metastatic Castrate Resistant Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Wichita Urology Group PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.